Christoffels, AlanMasiga, Daniel K.Berriman, MatthewLehane, MikeToure', YeyaAksoy, Serap2015-06-092015-06-092014Christoffels, A., et al. (2014). International Glossina Genome Initiative 2004–2014: a driver for post-genomic era research on the African continent. PLoS Neglected Tropical Diseases, 8(8): e3024. doi:10.1371/journal.pntd.00030241932-6203http://hdl.handle.net/10566/1498Human African trypanosomiasis (HAT), also known as sleeping sickness, is a neglected disease that impacts 70 million people distributed over 1.55 million km2 in sub- Saharan Africa and includes at least 50% of the population of theDemocratic Republic of the Congo [1]. Trypanosoma brucei gambiense accounts for more than 98% of the infections in central and West Africa, the remaining infections being from Trypanosoma brucei rhodesiense in East Africa [2]. The parasites are transmitted to the hosts through the bite of an infected tsetse fly. Disease control is challenging as there are no vaccines, and effective, easily delivered drugs are still lacking. Treatment invariably involves lengthy hospitalization, with both medical and socioeconomic consequences.en© 2014 Christoffels et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.Human African trypanosomiasis (HAT)Sleeping sicknessSub-Saharan AfricaDemocratic Republic of the CongoWorld Health Organization Tropical Diseases Research (WHOTDR)Article